The Neuro-Ophthalmology program at Weill Cornell Eye Associates serves patients with neurologic and systemic disorders that affect vision and eye movements, such as cerebrovascular disease, migraine, demylenation, thyroid disease, myasthenia, and other auto-immune disease. The program provides diagnosis and treatment for patients with double vision, blurred vision, transient or permanent loss of vision, or unusual visual phenomena. Special therapeutic strategies are available to assist patients recovering from double vision and visual field loss resulting from trauma, stoke, or neurosurgical procedures. Botulinum toxin therapy (BOTOX®) is available for patients diagnosed with blepharospasm or hemifacial spasm.
The Neuro-Ophthalmology Service is directed by Dr. Marc Dinkin, an expert in diagnosis and management of vascular disorders affecting vision.
Our specialists now see patients at two locations:
Weill Greenberg Center
1305 York Avenue
New York, NY 10021
156 William Street
New York, New York 10038
For consultation/referral/appointment requests, please call (646) 962-2020, or visit www.weillcornelleye.org.